"The agency added that the NIH has also determined there are currently insufficient data to recommend ivermectin for the treatment of COVID.

Not actually correct – the NIH current status on ivermectin is there is not enough data to recommend OR to discourage its use. The NIH changed this recommendation in December of 2020 as previously the NIH status on ivermectin usage was to discourage its use. Usually the status in which ivermectin is now placed would be accompanied with all kinds of funds to study the true efficacy of the drug, to see if it is successful. That of course is not being done at this time.

Interestingly, 2 of our other COVID modalities have exactly the same recommend/discourage status. That would be remdesevir and outpatient monoclonal antibodies. EXACTLY the same status on both of these as ivermectin currently. The NIH states there is not enough evidence to recommend or to discourage the use of either of these.

And yet we continue right on with both the others without a blink of an eye.

A little math –

Ivermectin course for COVID is less than twenty dollars.

A course of REMDESEVIR is currently right at 8800 dollars.

An outpatient treatment with monoclonal antibodies is right at 23000 – 25000 dollars with all the infusion costs added."

Hat tip to IM Doc (commentariat on Naked Capitalism....best source for info on Covid I've found...)